Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:924890rdf:typepubmed:Citationlld:pubmed
pubmed-article:924890lifeskim:mentionsumls-concept:C0007721lld:lifeskim
pubmed-article:924890lifeskim:mentionsumls-concept:C0007732lld:lifeskim
pubmed-article:924890lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:924890lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:924890lifeskim:mentionsumls-concept:C0337112lld:lifeskim
pubmed-article:924890pubmed:issue9lld:pubmed
pubmed-article:924890pubmed:dateCreated1978-1-27lld:pubmed
pubmed-article:924890pubmed:abstractTextCephaloglycin analogs with six-membered heterocycles in the C-3 side chain have been prepared by nucleophilic substitution of 7-aminocephalosporanic acid with appropriate azine thiols followed by 7-N-acylation with phenylglycine by the mixed anhydride method. Seventeen thiols of non-substituted or substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines were used as the S-nucleophiles. In general, pyridazine thiols gave cephalosporins processing good antimicrobial activity against both gram-positive and gram-negative bacteria. Among them 6-hydroxypyridazine-3-thiol gave the most active compound of this series, BB-S 118 (1f), which was significantly more active than cephalexin and cephaloglycin in vitro against gram-positive and gram negative bacteria.lld:pubmed
pubmed-article:924890pubmed:languageenglld:pubmed
pubmed-article:924890pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:924890pubmed:citationSubsetIMlld:pubmed
pubmed-article:924890pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:924890pubmed:statusMEDLINElld:pubmed
pubmed-article:924890pubmed:monthSeplld:pubmed
pubmed-article:924890pubmed:issn0021-8820lld:pubmed
pubmed-article:924890pubmed:authorpubmed-author:KasaiKKlld:pubmed
pubmed-article:924890pubmed:authorpubmed-author:NaitoTTlld:pubmed
pubmed-article:924890pubmed:authorpubmed-author:MasukoKKlld:pubmed
pubmed-article:924890pubmed:authorpubmed-author:OkumuraJJlld:pubmed
pubmed-article:924890pubmed:authorpubmed-author:HoshiHHlld:pubmed
pubmed-article:924890pubmed:issnTypePrintlld:pubmed
pubmed-article:924890pubmed:volume30lld:pubmed
pubmed-article:924890pubmed:ownerNLMlld:pubmed
pubmed-article:924890pubmed:authorsCompleteYlld:pubmed
pubmed-article:924890pubmed:pagination691-7lld:pubmed
pubmed-article:924890pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:924890pubmed:meshHeadingpubmed-meshheading:924890-A...lld:pubmed
pubmed-article:924890pubmed:meshHeadingpubmed-meshheading:924890-M...lld:pubmed
pubmed-article:924890pubmed:meshHeadingpubmed-meshheading:924890-B...lld:pubmed
pubmed-article:924890pubmed:meshHeadingpubmed-meshheading:924890-C...lld:pubmed
pubmed-article:924890pubmed:meshHeadingpubmed-meshheading:924890-C...lld:pubmed
pubmed-article:924890pubmed:meshHeadingpubmed-meshheading:924890-B...lld:pubmed
pubmed-article:924890pubmed:meshHeadingpubmed-meshheading:924890-C...lld:pubmed
pubmed-article:924890pubmed:year1977lld:pubmed
pubmed-article:924890pubmed:articleTitleCephalosporins. I. Cephaloglycin analogs with six-membered heterocycles in the C-3 side chain.lld:pubmed
pubmed-article:924890pubmed:publicationTypeJournal Articlelld:pubmed